files

Eli Lilly files oral rheumatoid arthritis drug baricitinib in US
Eli Lilly has filed its highly-anticipated rheumatoid arthritis treatment baricitinib in the US, setting the clock ticking on a possible approval later this year. The orally-active drug is considered a blockbuster contender on the back of clinical ... [...]
6
Like
Save